American Renal Associates Holdings Cash Flow - Annual (NYSE:ARA)

Add to My Stocks
$19.65 $0.01 (0.05%) ARA stock closing price Feb 21, 2018 (Closing)

The American Renal Associates Holdings cash flow statement helps investors understand how well the company is managing its cash flows. The profit-loss statement shows American Renal Associates Holdings profits, the balance sheet shows American Renal Associates Holdings debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the American Renal Associates Holdings stock analysis. American Renal Associates Holdings generated $172.21M cash from operating activities in 2016. The cash from operating activities for American Renal Associates Holdings is $ 2016, which saw an increase from previous year.

View details of American Renal Associates Holdings cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec2016201520142013
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow36.45M34.73M31.34M26.44M
Net Increase (Decrease) in Assets Liabilities14.33M2.52M-9.26M-1.29M
Cash From (used in) Discontinued Operations----
Other Adjustments Net33.21M3.25M13.76M27.39M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-61.43M-46.27M-39.84M-37.75M
Acquisition Disposition of Subsidiaires-4.5M-2.64M-5.08M-12.42M
Increase (Decrease) in Investments----
Other Cash Inflow (Outflow) from Investment Activities----
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares175.06M-4.62M-
Issuance (Repayment) of Debt Securities-144.65M19.26M12.23M220.23M
Increase (Decrease) in Bank & Other Borrowings----
Payment of Dividends & Other Cash Distributions-30.24M---199.68M
Other Cash from (used by) Financing Activities-96.51M-75.09M-61.57M-63.07M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year90.98M61.47M32.87M31.02M
Cash & Equivalents at Year End100.91M90.98M61.47M32.87M
All figures in USD. M: Millions of USD, B: Billions of USD.

While American Renal Associates Holdings stock price history provides the price history of a stock, American Renal Associates Holdings stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that American Renal Associates Holdings is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - American Renal Associates Holdings stock price movement.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a positive value of $172.21M for ARA.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-65.93M for ARA in last 2016 report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $-96.34M for American Renal Associates Holdings.

Key Financial Ratios For American Renal Associates Holdings Cash Flow

FCF margin

Annual Cash Flow Statements For American Renal Associates Holdings Inc Peers

Almost Family cash flow, Comprehensive Care cash flow, Gentiva Health Services cash flow, HANGER INC cash flow